4 responses to “Effects of glucocorticoids on cardiovascular risks in patients with rheumatoid arthritis”

  1. The risks and benefits of disease modifying medications also needs to be considered and tailored to individual patients.

  2. I agree with John Ryan’s comment–I would be interested in a head to head study comparing glucocorticoids and disease modifying agents with respect to side effects such as cardiovascular disease.

  3. I believed that as 10 mg/day of prednisone or equivalent are produced by the body a dose of 5 mg would be innocuous

  4. Interesting information as we have been told in the past that inflammation increases coronary risk and glucocorticoids are anti inflammatory agents.

Leave a Reply